Oscar Health (NYSE:OSCR) Trading 4.1% Higher

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) shares were up 4.1% on Wednesday . The company traded as high as $14.56 and last traded at $14.56. Approximately 283,240 shares traded hands during trading, a decline of 91% from the average daily volume of 3,217,866 shares. The stock had previously closed at $13.99.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on OSCR shares. TheStreet upgraded shares of Oscar Health from a "d" rating to a "c-" rating in a report on Wednesday, February 21st. The Goldman Sachs Group lifted their price objective on shares of Oscar Health from $8.00 to $16.00 and gave the company a "neutral" rating in a report on Friday, February 9th. Raymond James started coverage on shares of Oscar Health in a report on Friday, March 22nd. They set an "outperform" rating and a $20.00 price objective for the company. Finally, Wells Fargo & Company boosted their price target on shares of Oscar Health from $12.00 to $20.00 and gave the company an "overweight" rating in a report on Thursday, February 15th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $13.50.

Oscar Health Stock Performance

The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.19. The firm has a market cap of $3.43 billion, a P/E ratio of -12.44 and a beta of 1.79. The firm's fifty day moving average price is $15.11 and its 200 day moving average price is $10.37.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) EPS for the quarter, beating the consensus estimate of ($0.74) by $0.08. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The company's quarterly revenue was up 43.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($1.05) EPS. Sell-side analysts expect that Oscar Health, Inc. will post -0.23 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. CI Private Wealth LLC bought a new position in shares of Oscar Health during the 4th quarter worth approximately $38,000. Royal Bank of Canada raised its stake in shares of Oscar Health by 959.5% during the 3rd quarter. Royal Bank of Canada now owns 10,129 shares of the company's stock worth $50,000 after acquiring an additional 9,173 shares in the last quarter. Dark Forest Capital Management LP raised its stake in shares of Oscar Health by 5,243.2% during the 1st quarter. Dark Forest Capital Management LP now owns 7,801 shares of the company's stock worth $51,000 after acquiring an additional 7,655 shares in the last quarter. Alpine Global Management LLC bought a new position in shares of Oscar Health during the 4th quarter worth approximately $54,000. Finally, Squarepoint Ops LLC purchased a new stake in Oscar Health during the 4th quarter worth approximately $55,000. Institutional investors own 75.70% of the company's stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.